FTC Orders Divestitures In $4B Sun-Ranbaxy Pharma Merger

By Tom Zanki (January 30, 2015, 8:03 PM EST) -- The Federal Trade Commission cleared the controversial $4 billion merger of Indian drug companies Sun Pharmaceutical Industries Ltd. and Ranbaxy Laboratories Ltd. on Friday on the condition that Ranbaxy sell its interests in generic minocycline tablets to another company, defusing antitrust concerns....

Law360 is on it, so you are, too.

A Law360 subscription puts you at the center of fast-moving legal issues, trends and developments so you can act with speed and confidence. Over 200 articles are published daily across more than 60 topics, industries, practice areas and jurisdictions.


A Law360 subscription includes features such as

  • Daily newsletters
  • Expert analysis
  • Mobile app
  • Advanced search
  • Judge information
  • Real-time alerts
  • 450K+ searchable archived articles

And more!

Experience Law360 today with a free 7-day trial.

Start Free Trial

Already a subscriber? Click here to login

Hello! I'm Law360's automated support bot.

How can I help you today?

For example, you can type:
  • I forgot my password
  • I took a free trial but didn't get a verification email
  • How do I sign up for a newsletter?
Ask a question!